These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12659665)

  • 21. Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma.
    Dörner L; Mustafa A; Rohr A; Mehdorn HM; Nabavi A
    J Clin Neurosci; 2013 Mar; 20(3):429-34. PubMed ID: 23313517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
    Giese A; Bock HC; Kantelhardt SR; Rohde V
    Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
    Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
    Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
    Brem H; Mahaley MS; Vick NA; Black KL; Schold SC; Burger PC; Friedman AH; Ciric IS; Eller TW; Cozzens JW
    J Neurosurg; 1991 Mar; 74(3):441-6. PubMed ID: 1993909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
    Mack F; Schäfer N; Kebir S; Stuplich M; Schaub C; Niessen M; Scheffler B; Herrlinger U; Glas M
    Oncology; 2014; 86(5-6):369-72. PubMed ID: 24942787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
    World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
    Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
    World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
    Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
    Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
    Yerram P; Reiss SN; Modelevsky L; Gavrilovic IT; Kaley T
    J Neurooncol; 2019 Oct; 145(1):57-63. PubMed ID: 31432377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.
    Hall DE; Moffat BA; Stojanovska J; Johnson TD; Li Z; Hamstra DA; Rehemtulla A; Chenevert TL; Carter J; Pietronigro D; Ross BD
    Clin Cancer Res; 2004 Dec; 10(23):7852-9. PubMed ID: 15585617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapeutic wafers in treatment of malignant cerebral glioma. Assessment of a Cochrane review].
    Kosteljanetz M; Poulsen HS
    Ugeskr Laeger; 2010 Jan; 172(3):214-7. PubMed ID: 20089214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temozolomide in the treatment of recurrent malignant glioma.
    Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
    Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
    Emerich DF; Winn SR; Bartus RT
    Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme.
    Darakchiev BJ; Albright RE; Breneman JC; Warnick RE
    J Neurosurg; 2008 Feb; 108(2):236-42. PubMed ID: 18240917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.
    Blakeley JO; Grossman SA; Mikkelsen T; Rosenfeld MR; Peereboom D; Nabors LB; Chi AS; Emmons G; Garcia Ribas I; Supko JG; Desideri S; Ye X
    J Neurooncol; 2015 Oct; 125(1):123-31. PubMed ID: 26285766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.
    Holdhoff M; Ye X; Supko JG; Nabors LB; Desai AS; Walbert T; Lesser GJ; Read WL; Lieberman FS; Lodge MA; Leal J; Fisher JD; Desideri S; Grossman SA; Wahl RL; Schiff D
    Neuro Oncol; 2017 Jun; 19(6):845-852. PubMed ID: 28371832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
    Cloughesy TF; Kuhn J; Robins HI; Abrey L; Wen P; Fink K; Lieberman FS; Mehta M; Chang S; Yung A; DeAngelis L; Schiff D; Junck L; Groves M; Paquette S; Wright J; Lamborn K; Sebti SM; Prados M
    J Clin Oncol; 2005 Sep; 23(27):6647-56. PubMed ID: 16170172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
    Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.